These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 19505923)
1. Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis. Sood AK; Wang J; Mhawech-Fauceglia P; Jana B; Liang P; Geradts J Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1899-903. PubMed ID: 19505923 [TBL] [Abstract][Full Text] [Related]
2. The ets-domain transcription factor Spdef promotes maturation of goblet and paneth cells in the intestinal epithelium. Gregorieff A; Stange DE; Kujala P; Begthel H; van den Born M; Korving J; Peters PJ; Clevers H Gastroenterology; 2009 Oct; 137(4):1333-45.e1-3. PubMed ID: 19549527 [TBL] [Abstract][Full Text] [Related]
3. Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. Turner DP; Moussa O; Sauane M; Fisher PB; Watson DK Cancer Res; 2007 Feb; 67(4):1618-25. PubMed ID: 17308102 [TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex. Cho JY; Lee M; Ahn JM; Park ES; Cho JH; Lee SJ; Kim BG; Heo SH; Park HJ; Zerbini LF; Hwang D; Libermann TA J Proteome Res; 2009 Mar; 8(3):1327-37. PubMed ID: 19203193 [TBL] [Abstract][Full Text] [Related]
5. Enhanced motility of KGF-transfected breast cancer cells. Zang XP; Bullen EC; Manjeshwar S; Jupe ER; Howard EW; Pento JT Anticancer Res; 2006; 26(2A):961-6. PubMed ID: 16619493 [TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma. González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of an Ets protein, PEA3, in breast cancer cell lines MDA-MB-361DYT2 and BT474M1. Yu Z; Xia W; Wang HY; Wang SC; Pan Y; Kwong KY; Hortobagyi GN; Hung MC Mol Carcinog; 2006 Sep; 45(9):667-75. PubMed ID: 16652376 [TBL] [Abstract][Full Text] [Related]
8. Prostate-derived Ets factor, an oncogenic driver in breast cancer. Sood AK; Geradts J; Young J Tumour Biol; 2017 May; 39(5):1010428317691688. PubMed ID: 28468594 [TBL] [Abstract][Full Text] [Related]
9. Lineage infidelity and expression of melanocytic markers in human breast cancer. Bachmeier BE; Nerlich AG; Mirisola V; Jochum M; Pfeffer U Int J Oncol; 2008 Nov; 33(5):1011-5. PubMed ID: 18949364 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells. Singh B; Cook KR; Vincent L; Hall CS; Berry JA; Multani AS; Lucci A J Surg Res; 2008 Jun; 147(2):240-6. PubMed ID: 18498876 [TBL] [Abstract][Full Text] [Related]
11. Growth suppression of MCF-7 cancer cell-derived xenografts in nude mice by caveolin-1. Wu P; Wang X; Li F; Qi B; Zhu H; Liu S; Cui Y; Chen J Biochem Biophys Res Commun; 2008 Nov; 376(1):215-20. PubMed ID: 18778685 [TBL] [Abstract][Full Text] [Related]
12. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor. Steffan JJ; Koul HK Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of basal-like subtype in triple-negative breast cancer. Yamamoto Y; Ibusuki M; Nakano M; Kawasoe T; Hiki R; Iwase H Breast Cancer; 2009; 16(4):260-7. PubMed ID: 19701681 [TBL] [Abstract][Full Text] [Related]
14. Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo. Akiri G; Sabo E; Dafni H; Vadasz Z; Kartvelishvily Y; Gan N; Kessler O; Cohen T; Resnick M; Neeman M; Neufeld G Cancer Res; 2003 Apr; 63(7):1657-66. PubMed ID: 12670920 [TBL] [Abstract][Full Text] [Related]
15. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition. Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923 [TBL] [Abstract][Full Text] [Related]
16. Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment. Furlan A; Vercamer C; Desbiens X; Pourtier A J Cell Physiol; 2008 Jun; 215(3):782-93. PubMed ID: 18181172 [TBL] [Abstract][Full Text] [Related]
17. SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer. Cheng CJ; Lin YC; Tsai MT; Chen CS; Hsieh MC; Chen CL; Yang RB Cancer Res; 2009 Apr; 69(8):3634-41. PubMed ID: 19369267 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells. Gomes EM; Rodrigues MS; Phadke AP; Butcher LD; Starling C; Chen S; Chang D; Hernandez-Alcoceba R; Newman JT; Stone MJ; Tong AW Clin Cancer Res; 2009 Feb; 15(4):1317-25. PubMed ID: 19228733 [TBL] [Abstract][Full Text] [Related]
19. E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription. Jiang J; Wei Y; Liu D; Zhou J; Shen J; Chen X; Zhang S; Kong X; Gu J Biochem Biophys Res Commun; 2007 Jun; 358(1):53-8. PubMed ID: 17467662 [TBL] [Abstract][Full Text] [Related]
20. SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1. Wu J; Qin W; Wang Y; Sadik A; Liu J; Wang Y; Song P; Wang X; Sun K; Zeng J; Wang L J Cell Biochem; 2018 Nov; 119(11):9042-9054. PubMed ID: 30076647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]